INSIGHTS ON QUALITY CONTROL

• 9 Pillars Of Inspection Readiness For GMP Manufacturers: A Practical CSA Playbook

  Inspection readiness depends on operational systems rather than last-minute preparation. A nine-part framework traces where inspectors look, and where maintenance, calibration, and equipment records carry the most weight.

• Antibiotic Potency Testing By Microbial Assay

  Selecting a potency assay for antibiotic drug substances and products carries regulatory, operational, and lifecycle implications that extend well beyond the laboratory.

• Late‑Stage Progress In Excipients For Precision Nanomedicine

  View late‑stage development and GMP manufacturing of novel excipients for nanomedicines, emphasizing regulatory rigor, process optimization, analytics, and scale‑up for lipid‑based delivery systems.

• Controlling Nitrosamine Risk In Drug Products: Detection, Formation, And Control Strategies

  Bioprocess control relies on clear insight into cell health. Automated tracking cuts risk, saves time, boosts yield, and helps scale up fast to ensure smooth, top quality batch production runs daily.

• High Precision Mass Inspection With Accuracy Of ±0.5 mg Achieved

  7/2/2026

  Explore how advances in capsule checkweighing technology enable more precise mass inspection, helping improve quality control, reduce variability, and meet increasingly stringent production requirements.

• Connected By Design: Laboratory Automation And Digital Transformation Strategy

  10/19/2026

  Task-level automation delivers isolated gains, but the larger payoff in GxP laboratories comes from connecting instruments, systems, and data into workflows where samples move with minimal human handoffs.

• Factory Acceptance Testing (FAT): Pre-Shipment Quality Verification Guide

  7/6/2026

  Quality control begins long before installation. Discover how pre-shipment testing mitigates risk, ensures specification compliance, and streamlines cleanroom project timelines.

• Aggregate Analysis Of Tirzepatide

  12/11/2025

  A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.

• The AI Advantage For Regulated Manufacturing

  6/10/2026

  Transitioning from paper batch records to human-centered AI optimizes pharma manufacturing. Learn to secure data, cut review times by 90%, and build a strong Return on Automation business case.